This inventor holds 1 USPTO granted patent. Top assignee: Pfizer Corporation. Active years: 2007.
Company Filing History:
Years Active: 2007
Title: Innovations by Christopher James in Anti-Tumor Compounds
Introduction
Christopher James is an accomplished inventor based in Arese, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral formulations for anti-tumor compounds. His innovative work has the potential to impact cancer treatment positively.
Latest Patents
Christopher holds a patent for a unique formulation that includes a camptothecin derivative, a pharmaceutically acceptable carrier matrix, and a combination of excipients that enhance the formulation's stability and effectiveness. This patent is a testament to his dedication to advancing medical science and improving patient outcomes. He has 1 patent to his name.
Career Highlights
Christopher is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His role involves research and development, where he focuses on creating effective treatments for various medical conditions. His expertise and innovative mindset have made him a valuable asset to the company.
Collaborations
Throughout his career, Christopher has collaborated with talented professionals, including Lorena Muggetti and Alessandro Martini. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking solutions in the pharmaceutical industry.
Conclusion
Christopher James exemplifies the spirit of innovation in the pharmaceutical field. His work on anti-tumor compounds showcases his commitment to improving healthcare through scientific advancements. His contributions are paving the way for future breakthroughs in cancer treatment.